Koleka Mlisana
Koleka Mlisana
Professor of Medical Microbiology, University of KwaZulu-Natal and National Health Laboratory
Verified email at ukzn.ac.za
Title
Cited by
Cited by
Year
Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women
QA Karim, SSA Karim, JA Frohlich, AC Grobler, C Baxter, LE Mansoor, ...
science 329 (5996), 1168-1174, 2010
3421*2010
The neutralization breadth of HIV-1 develops incrementally over four years and is associated with CD4+ T cell decline and high viral load during acute infection
ES Gray, MC Madiga, T Hermanus, PL Moore, CK Wibmer, NL Tumba, ...
Journal of virology 85 (10), 4828-4840, 2011
4812011
Quantitating the multiplicity of infection with human immunodeficiency virus type 1 subtype C reveals a non-poisson distribution of transmitted variants
MR Abrahams, JA Anderson, EE Giorgi, C Seoighe, K Mlisana, LH Ping, ...
Journal of virology 83 (8), 3556-3567, 2009
4342009
Genetic and neutralization properties of subtype C human immunodeficiency virus type 1 molecular env clones from acute and early heterosexually acquired infections in Southern …
M Li, JF Salazar-Gonzalez, CA Derdeyn, L Morris, C Williamson, ...
Journal of virology 80 (23), 11776-11790, 2006
4002006
Neutralizing antibody responses in acute human immunodeficiency virus type 1 subtype C infection
ES Gray, PL Moore, IA Choge, JM Decker, F Bibollet-Ruche, H Li, ...
Journal of virology 81 (12), 6187-6196, 2007
3682007
Safety and efficacy of the HVTN 503/Phambili study of a clade-B-based HIV-1 vaccine in South Africa: a double-blind, randomised, placebo-controlled test-of-concept phase 2b study
GE Gray, M Allen, Z Moodie, G Churchyard, LG Bekker, M Nchabeleng, ...
The Lancet infectious diseases 11 (7), 507-515, 2011
3652011
Emergence and rapid spread of a new severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2) lineage with multiple spike mutations in South Africa
H Tegally, E Wilkinson, M Giovanetti, A Iranzadeh, V Fonseca, ...
medRxiv, 2020
3352020
Limited neutralizing antibody specificities drive neutralization escape in early HIV-1 subtype C infection
PL Moore, N Ranchobe, BE Lambson, ES Gray, E Cave, MR Abrahams, ...
PLoS Pathog 5 (9), e1000598, 2009
2422009
Transmission of extensively drug-resistant tuberculosis in South Africa
NS Shah, SC Auld, JCM Brust, B Mathema, N Ismail, P Moodley, ...
New England Journal of Medicine 376 (3), 243-253, 2017
2292017
Plasma cytokine levels during acute HIV-1 infection predict HIV disease progression
L Roberts, JAS Passmore, C Williamson, F Little, LM Bebell, K Mlisana, ...
AIDS (London, England) 24 (6), 819, 2010
2172010
Evolution of extensively drug-resistant tuberculosis over four decades: whole genome sequencing and dating analysis of Mycobacterium tuberculosis isolates from KwaZulu-Natal
KA Cohen, T Abeel, AM McGuire, CA Desjardins, V Munsamy, TP Shea, ...
PLoS Med 12 (9), e1001880, 2015
2052015
Establishing a cohort at high risk of HIV infection in South Africa: challenges and experiences of the CAPRISA 002 acute infection study
F Van Loggerenberg, K Mlisana, C Williamson, SC Auld, L Morris, ...
PloS one 3 (4), e1954, 2008
2002008
The c3-v4 region is a major target of autologous neutralizing antibodies in human immunodeficiency virus type 1 subtype C infection
PL Moore, ES Gray, IA Choge, N Ranchobe, K Mlisana, SSA Karim, ...
Journal of virology 82 (4), 1860-1869, 2008
1862008
Symptomatic vaginal discharge is a poor predictor of sexually transmitted infections and genital tract inflammation in high-risk women in South Africa
K Mlisana, N Naicker, L Werner, L Roberts, F Van Loggerenberg, ...
The Journal of infectious diseases 206 (1), 6-14, 2012
1842012
Potent and broad neutralization of HIV-1 subtype C by plasma antibodies targeting a quaternary epitope including residues in the V2 loop
PL Moore, ES Gray, D Sheward, M Madiga, N Ranchobe, Z Lai, ...
Journal of virology 85 (7), 3128-3141, 2011
1772011
Transmission of HIV-1 CTL escape variants provides HLA-mismatched recipients with a survival advantage
DR Chopera, Z Woodman, K Mlisana, M Mlotshwa, DP Martin, C Seoighe, ...
PLoS Pathog 4 (3), e1000033, 2008
1612008
Defining genital tract cytokine signatures of sexually transmitted infections and bacterial vaginosis in women at high risk of HIV infection: a cross-sectional study
L Masson, K Mlisana, F Little, L Werner, NN Mkhize, K Ronacher, ...
Sexually transmitted infections 90 (8), 580-587, 2014
1412014
Genomic and functional analyses of Mycobacterium tuberculosis strains implicate ald in D-cycloserine resistance
CA Desjardins, KA Cohen, V Munsamy, T Abeel, K Maharaj, BJ Walker, ...
Nature genetics 48 (5), 544-551, 2016
1352016
Recombinant adenovirus type 5 HIV gag/pol/nef vaccine in South Africa: unblinded, long-term follow-up of the phase 2b HVTN 503/Phambili study
GE Gray, Z Moodie, B Metch, PB Gilbert, LG Bekker, G Churchyard, ...
The Lancet infectious diseases 14 (5), 388-396, 2014
1282014
Broad neutralization of human immunodeficiency virus type 1 mediated by plasma antibodies against the gp41 membrane proximal external region
ES Gray, MC Madiga, PL Moore, K Mlisana, SSA Karim, JM Binley, ...
Journal of virology 83 (21), 11265-11274, 2009
1172009
The system can't perform the operation now. Try again later.
Articles 1–20